Identification | Back Directory | [Name]
1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl methanesulfonate | [CAS]
477781-69-4 | [Synonyms]
Benzyl-PEG4-MS CAS_477781-69-4 MsO-(CH2CH2O)4-Bn 1-Phenyl-2,5,8,11-tetraoxatridecan-13-yl methanesulfonate 3,6,9,12-Tetraoxatridecan-1-ol, 13-phenyl-, 1-methanesulfonate | [Molecular Formula]
C16H26O7S | [MDL Number]
MFCD30342472 | [MOL File]
477781-69-4.mol | [Molecular Weight]
362.44 |
Hazard Information | Back Directory | [Uses]
Benzyl-PEG4-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [Synthesis]
1. To a stirred mixture of 1-phenyl-2,5,8,11-tetraoxatridecan-13-ol (45.1 g, 159 mmol) and triethylamine (62.2 g, 636 mmol) in dichloromethane (800 mL) at 0 °C was slowly added methanesulfonyl chloride (36.4 g, 318 mmol).
2. After addition, the reaction mixture was stirred at room temperature overnight.
3. Upon completion of the reaction, the reaction was quenched with 1N HCl (300 mL) and then extracted with ethyl acetate.
4. The organic phases were combined, dried over magnesium sulfate, concentrated to dryness, and purified by fast chromatography to afford 1-benzyloxytrioxaundecanemethanesulfonate (56.2 g, 98%) as a clear oil.
1H NMR (400MHz, CDCl3) δ 7.25-7.32 (m, 5H), 4.54 (s, 2H), 4.32-4.34 (m, 2H), 3.71-3.73 (m, 2H), 3.59-3.66 (m, 12H), 3.03 (s, 3H). | [IC 50]
PEGs | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
|
Company Name: |
Henan Alfachem Co.,Ltd.
|
Tel: |
0371-55051623 18137891487 |
Website: |
www.chemicalbook.com/supplier/14555231/ |
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
Company Name: |
Wuhan Topule
|
Tel: |
+86-02787215551 +86-19945035818 |
Website: |
http://www.topule.com/ |
|